Market Probability

No market

Status

Introduced

Committee

Floor Vote

Other Chamber

Signed

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Rep. Matsui, Doris O. [D-CA-7](D-CA-7)

13 cosponsors

Summary

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Subjects

CancerHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careMedicaidMedical tests and diagnostic methodsMedicarePoverty and welfare assistanceState and local government operations

Actions (4)

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 26, 2025House floor actions

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Feb 26, 2025House floor actions

Introduced in House

Feb 26, 2025Library of Congress

Introduced in House

Feb 26, 2025Library of Congress